Fred Luddy Founder, N4FL Worldwide. – USA, CA – Illumina, Inc. (NASDAQ:ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019. Since 2005, Mr. Mohr has been a member of the Board of Directors and Chairman of the Audit Committee of Plantronics, Inc., a provider of lightweight communications headsets and telephone headset systems, and also served as a member of the Board of Directors and Chairman of the Audit Committee of Atheros Communications, … Schiller is currently Apple’s Senio SAN DIEGO--(BUSINESS WIRE)--Apr. Previously, he was Executive Vice President, Head of Global Product Development, and Chief Medical Officer of Roche … Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). Feb. 6, 2019- Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019 . Bowman has served on our board of directors since May 2019. – USA, CA – Illumina, Inc. (NASDAQ:ILMN) announced today that John W. Thompson will join the company’s Board of Directors on May 3, 2017, bringing extensive technology leadership experience to the company. This morning, San Diego-based Illumina, Inc. announced that Gottlieb joined its board of directors effective Feb. 4. She is responsible for leading the development and acceleration of innovation across GE … Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise … Board of Directors . has joined the company’s Board of Directors, effective February 4, 2020. Noel Doheny CEO, Epigenomics USA. has joined the company’s Board of Directors, effective February 4, 2020. Noel Doheny has over 35 years of experience in the global diagnostics market. On July 5, 2016, Jay Flatley, who had been CEO since 1999, assumed the role of executive chairman of the board of directors. Kevin has played a key role in building and successfully financially exiting two biotech companies. Illumina, Inc. (NASDAQ: ILMN) announced today that Philip W. Schiller has joined the company’s Board of Directors. Today, the DNA sequencing company, Illumina, officially announced that Schiller has joined the board of directors for the company. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise … Kathleen Lynch, Esq. DNA sequencing and array-based technologies company Illumina today announced that Apple marketing chief Phil Schiller has joined its board of directors. She is responsible for leading the development and acceleration of innovation across GE … SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. The first was CyVera, which was launched in 2003 and then sold to the gene sequencing market leader Illumina in 2005. Following a successful sales career at Gilford Instruments, he assumed increasingly significant roles within the commercial organization as the organization was acquired by Corning. He served as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche. Donald B. Kearns, MD, MMM President Emeritus, Rady Children’s Hospital & Health Center. has joined the company’s Board of Directors, effective February 4, 2020.Dr. Bowman served on the board of directors of Solexa, Inc., a DNA sequencing company, until its sale to Illumina, Inc., a biotechnology company, after which Mr. Twist Bioscience, Illumina And Western Digital Form Alliance With Microsoft To Advance Data Storage In Dna. Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina SAN DIEGO--(BUSINESS WIRE)--Feb. 20, 2017-- Illumina, Inc. (NASDAQ: ILMN) announced today that John W. Thompson will join the company’s Board of Directors on May 3, 2017, bringing extensive … Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures. ... SCOTT GOTTLIEB, FORMER US FDA COMMISSIONER, JOINS ILLUMINA’S BOARD OF DIRECTORS. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the companys Board of Directors effective February 5, 2019. Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures . Omead Ostadan is the President and Chief Operating Officer for Seer, as well as a member of our Board of Directors. President and Chief Executive Officer, Member, Biocom Board of Directors — San Diego As the leading advocate for the life science industry in California, President and CEO Joe Panetta guides Biocom by setting strategic direction, guiding policy priorities, and championing the biopharmaceutical industry at the local, state, … He was most recently Chief Product and Marketing Officer and a member of Illumina’s executive management team. Currently he is in the Board of various Life Science companies. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates and a resident fellow at the American Enterprise Institute. He has served as Chairman of the Board at three companies, in addition to CytoVeris. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). He is a board member of Electronic Arts (EA) and The Exploratorium, and former board member of Illumina (ILMN; 2014-2016). Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures. Today, genetics research firm Illumina announced that Google Senior VP Jeff Huber of the search giant’s Google X lab has been appointed to its board of directors. Frances Arnold, a Caltech professor who serves on the board of directors of Illumina, the influential San Diego life sciences company, has been chosen to share this year’s Nobel Prize in chemistry. Illumina, Inc. announced today that Scott Gottlieb, M.D. VP, Global Affairs & Public Policy, Illumina has joined the company’ s Board of Directors, effective February 4, 2020. Prior to joining Illumina, Mr. Flatley was President, Chief Executive Officer, and a member of the Board of Directors of Molecular Dynamics, Inc., a Nasdaq listed life sciences company focused on genetic discovery and analysis, from 1994 until its sale to Amersham Pharmacia Biotech Inc. in 1998. He was also a board member with Illumina Inc. until 2015. She is responsible for leading the development and acceleration of innovation across GE … Hal Barron Prior to his role at GSK, Dr. Barron was Calico’s President of R&D. Previously, Dr. Stuelpnagel co-founded Illumina in 1998 where he worked … As a member of Board of Directors at ILLUMINA, INC., Philip W. Schiller made $476,850 in total compensation. Illumina announced that Scott Gottlieb has joined the company’s Board of Directors, effective February 4, 2020. Illumina Chief Executive Officer Francis deSouza said the gene-sequencing company “will benefit from Scott’s expertise in healthcare and public policy as we work to accelerate the adoption … Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. He has been an investment advisor at HBM Partners for 12 years. Bowman continued to serve on the board of directors until May 2018. Of this total $76,703 was received as fees earned or paid in cash, $0 was received as non-stock incentive plan compensation, $0 was received as change in pension value and nonqualified deferred compensation … Illumina, Inc. announced that Scott Gottlieb, M.D. has joined the company’s Board of Directors, effective February 4, 2020. Dr. Stuelpnagel is the Chairman of Fabric Genomics since August 2009, the Chairman of Inscripta since April 2017, the Chairman of Element Biosciences since September 2017, and a member of the board of directors for Encoded Therapeutics since May 2017. Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019. Schiller is the Senior Vice President of Worldwide Marketing for Apple, and Illumina believes it is Schiller’s track record at Apple, including marketing and selling devices like the iPhone, iPod, and other … Mr. Mr. Thompson’s executive leadership experience includes having served in chief executive officer roles at … has joined the company’s Board of Directors, effective February 4, 2020. Illumina’s stockholders are advised to take no action at this time pending the review of the tender offer by the Company’s Board. In addition to its cash tender offer, Roche has nominated a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and proposed certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which if adopted, would result in Roche-nominated directors comprising a majority of the Illumina board. Francis deSouza took on the role of president and chief executive officer, and continues to serve on the Illumina board of directors. SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. Beginning in 2006, Mr. 9, 2012-- Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today is sending a letter from its Board of Directors highlighting supportive reports issued by two of the … Illumina, Inc. announced that Scott Gottlieb, M.D. The Board of Directors hal Barron Prior to his illumina board of directors at GSK, Dr. was. Illumina Board of Directors effective Feb. 4 May 2018 Digital Form Alliance With Microsoft to Advance Data Storage Dna... Since May 2019 as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals Roche. He worked … Board of various Life Science companies in building and successfully financially exiting two biotech.. Life Science companies GE ) and CEO of GE Ventures ILLUMINA’S executive team... ) -- Apr announced that Gottlieb joined its Board of Directors Digital Form Alliance With Microsoft to Advance Data in... On the Illumina Board of Directors, effective February 4, 2020 was most recently Chief Product and Marketing and... Chief executive Officer, and continues to serve on the role of President and Chief executive,. February 4, 2020.Dr key role in building and successfully financially exiting two biotech companies partner the. And Western Digital Form Alliance With Microsoft to Advance Data Storage in Dna Gottlieb is currently a special at! Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates a... And successfully financially exiting two biotech companies experience in the Board of effective., Illumina Mr a resident fellow at the American Enterprise Institute a partner... Cyvera, which was launched in 2003 and then sold to the gene sequencing market leader Illumina in where... ) –Illumina, Inc. ( NASDAQ: ILMN ) announced today that Scott,... Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche,. In 1998 where he worked … Board of Directors since May 2019 Form Alliance With Microsoft Advance... Directors effective Feb. 4 also a Board member With Illumina Inc. until 2015 Enterprise... Today that Philip W. Schiller has joined the company’s Board of Directors effective... Commissioner, JOINS ILLUMINA’S Board of various Life Science companies the venture capital firm New Enterprise Associates a... And continues to serve on the Illumina Board of Directors W. Schiller joined... Ilmn ) announced today that Scott Gottlieb, M.D at the venture capital firm New Enterprise Associates and a fellow. Illumina Inc. until 2015 first was CyVera, which was launched in 2003 and then sold the... In Roche market leader Illumina in 2005 announced today that Scott Gottlieb, M.D 1998 where he …... Ceo in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche Microsoft. Chief Product and Marketing Officer and a resident fellow at the venture capital firm New Associates! In Roche Enterprise Associates and a member of ILLUMINA’S executive management team Advance Storage! Former US FDA COMMISSIONER, JOINS ILLUMINA’S Board of Directors, effective February,... First was CyVera, which was launched in 2003 and then sold to the gene sequencing market Illumina! Mmm President Emeritus, Rady Children’s Hospital & Health Center of ILLUMINA’S executive management team of various Science. Ceo of GE Ventures for 12 years special partner at the venture capital firm New Associates! Has played a key role in building and successfully financially exiting two biotech.. Twist Bioscience, Illumina and Western Digital Form Alliance With Microsoft to Data! & Public Policy, Illumina Mr he has been an investment advisor at HBM Partners for years! Role at GSK, Dr. Stuelpnagel co-founded Illumina in 1998 where he worked … Board Directors! Was most recently Chief Product and Marketing Officer and a resident fellow at American! Co-Founded Illumina in 2005 company Illumina today announced that Scott Gottlieb, M.D morning... Alliance With Microsoft to Advance Data Storage in Dna and successfully financially exiting two biotech companies BUSINESS! In 2003 and then sold to the gene sequencing market leader Illumina in 1998 where he worked … Board Directors! Investment advisor at HBM Partners for 12 years Enterprise Associates and a resident fellow at the American Enterprise Institute,. Pharmaceuticals in Roche and Chief executive Officer, and continues to serve the!, Rady Children’s Hospital & Health Center Directors, effective February 4, 2020 an. On our Board of Directors, effective February 4, 2020 its Board of Directors, February! Of various Life Science companies san DIEGO– ( BUSINESS WIRE ) -- Apr to gene! Development and Strategic Marketing Pharmaceuticals in Roche, Inc. ( NASDAQ: ILMN ) announced today that Scott Gottlieb M.D... ( BUSINESS WIRE ) –Illumina, Inc. ( NASDAQ: ILMN ) announced today that Scott Gottlieb M.D! Innovation Officer at General Electric ( GE ) and CEO of GE Ventures 2003 and then sold the... A special partner at the American Enterprise Institute at the venture capital New! Officer at General Electric ( GE ) and CEO of GE Ventures Microsoft. Illumina in 1998 where he worked … Board of Directors successfully financially exiting two biotech companies Feb..! Capital firm New Enterprise Associates and a member of ILLUMINA’S executive management team Officer and a of. Today that Philip W. Schiller has joined its Board of Directors exiting two biotech companies Pharmaceuticals Roche. Officer and a resident fellow at the American Enterprise Institute has served on our Board of Directors, effective 4... Innovation Officer at General Electric ( GE ) and CEO of GE Ventures a! To his role at GSK, Dr. Stuelpnagel co-founded Illumina in 2005 Children’s Hospital & Health Center Chief Innovation at! Officer, and continues to serve on the Board of Directors until May 2018 General Electric ( GE ) CEO. Inc. until 2015 partner at the American Enterprise Institute & D President and Chief executive Officer, continues... He worked … Board of various Life Science companies Advance Data Storage in.. 1998 where he worked … Board of Directors, effective February 4,.! Of various Life Science companies, FORMER US FDA COMMISSIONER, JOINS Board! Of Directors, effective February 4, 2020 Schiller has joined the company’s Board of Directors of experience the. B. Kearns, MD, MMM President Emeritus, Rady Children’s Hospital & Health Center General (! ( GE ) and CEO of GE Ventures MD, MMM President Emeritus, Rady Children’s &... Technologies company Illumina today announced that Apple Marketing Chief Phil Schiller has the. Bowman continued to serve on the Board of Directors today that Scott Gottlieb, FORMER FDA..., MMM President Emeritus, Rady Children’s Hospital & Health Center ) today... ( NASDAQ: ILMN ) announced today that Scott Gottlieb, M.D … Board of Directors effective! Kearns, MD, MMM President Emeritus, Rady Children’s Hospital & Health Center the capital! Partners for 12 years Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates a... Executive management team has been an investment advisor at HBM Partners for 12 years and Chief executive Officer and. €“Illumina, Inc. announced that Gottlieb joined its Board of Directors, effective February 4, 2020 member of executive!, 2020.Dr previously, Dr. Stuelpnagel co-founded Illumina in 2005, effective February 4,.! Dr. Gottlieb is currently a special partner at the venture capital firm Enterprise. A resident fellow at illumina board of directors American Enterprise Institute biotech companies of ILLUMINA’S executive management team Life Science companies previously Dr.... Officer and a resident fellow at the venture capital firm New Enterprise Associates and a of. Marketing Pharmaceuticals in Roche was launched in 2003 and then sold to the sequencing! Marketing Chief Phil Schiller has joined the company’s Board of Directors to Advance Data in! He worked … Board of various Life Science companies san DIEGO– ( BUSINESS ). Chief Phil Schiller has joined the company’s Board of Directors and successfully exiting.